Novartis Venture Fund is a corporate venture capital firm in Switzerland that focuses on companies that develop novel therapeutics and platforms. Founded 1996 in Basel-Stadt, Switzerland by Argeris Karabelas, it invests in early stage ventures, late stage venture, post-IPO, secondary markets, seed, series A, series B, series C, and post-IPO equity. Its portfolio companies include TScan Therapeutics, GenSight Biologics, FORMA Therapeutics, Arctos Medical, and Enterprise Therapeutics. As of March 2020, Novartis Venture Fund has made 200 investments. Their most recent investment was on January 10, 2020, when TScan Therapeutics raised $35M. Novartis Venture Fund has had 51 exits, the most notable of which include PTC Therapeutics, Bicycle Therapeutics, and Akebia Therapeutics. The company has raised three funds, their latest being Novartis Option Fund (NOF). This fund was announced on January 1, 2009 and raised a total of $200M.
Timeline
Founded
Funded Companies
Nabriva TherapeuticsA biopharmaceutical company focused on the research and development of antibiotics to treat serious infections
Dublin
Ireland
Akebia TherapeuticsA company developing Hypoxia Inducible Factor therapies to treat kidney diseases and other conditions
Cambridge, Massachusetts
United States
Galera TherapeuticsA company developing therapeutics for the treatment of cancer
Malvern, Arkansas
Adicet BioAdicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases.
Menlo Park, California
Lemonaid HealthA provider of an online telemedicine service in California and focuses on creating a revolutionized patient experience and improving and optimizing clinical care through the advancements in machine learning and AI.
San Francisco
ImaginAbImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient's health--enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs.
Los Angeles
Inglewood, California
Oculis Labs
Iceland
Baltimore
Omeros (company)Omeros is a Seattle-based biotechnology company founded by Konrad Tylka.
Seattle
PulmatrixA company developing inhaled therapies to treat, prevent the spread of infectious and progressive respiratory diseases
Lexington, Virginia
Lexington, Massachusetts
Aileron TherapeuticsA biopharmaceutical company developing stapled peptide therapeutics for the treatment of cancers and other diseases
Advanced Animal DiagnosticsA company developing diagnostic products to cure on-farm animal diseases
Durham, North Carolina
Catalyst BiosciencesA pharmaceutical company developing products to address hemophilia
South San Francisco, California
Effector TherapeuticsA company dedicated on the discovery and development of small molecule therapeutics to treat cancer
San Diego
Alios BiopharmaA biotechnology company developing medicines to treatment viral diseases
GlycoMimeticsA biotechnology company developing treatments for sickle cell, cancer and other serious disease
Gaithersburg, Maryland
CovagenA biopahramaceutical company developing protein-based therapeutics to treat inflammatory diseases and cancer
Anchor TherapeuticsA company developing pepducin technology to produce therapeutics for regenerative medicine, diabetes, inflammation and cancer.
Cambridge, Cambridgeshire
ProCertus BioPharmA oncology-based pharmaceutical company developing therapeutics for the protection of cancer patients from radiotherapy and chemotherapy side effects
Madison, Wisconsin
EraGen BiosciencesA biotechnology company developing molecular reagent products and software for research and diagnostics
CelladonA biotechnology company focused in the development of molecular therapies to treat heart failure
Artios PharmaArtios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells
Tokai PharmaceuticalsA company that develops and commercializes therapies for prostate cancer and other hormonally-driven diseases
OxagenA biopharmaceutical company developing small molecule drugs for asthma, chronic allergy and inflammatory conditions
IntradigmA biotechnology company that develops RNA interference therapeutics
Palo Alto, California
LigoCyte PharmaceuticalsA company that develops vaccines and monoclonal antibodies to treat gastrointestinal and respiratory conditions
Bozeman, MontanaPeople
Bart Dzikowski
Head of Legal
David Morris
Venture Partner
Harry Kirsch
Chief Financial Officer
Lauren Silverman
Managing Director
Spyros Artavanis-Tsakonas
Chairman, Option Fund
Further reading
Documentaries, videos and podcasts
Companies
Twentyeight-Seven Therapeutics
Adicet Bio
Anaveon
Anokion
Athelas
Cala Health
Forendo Pharma
Renovacor
TScan Therapeutics
References
Novartis Venture Fund
Venture capital firm
CompanyCompany attributes
Venture capital
Basel
NovartisVenture Capital Firm attributes
Cala Health
TScan TherapeuticsCategories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna-Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Melanie Manipula
Researcher, writer and a former librarian - 3
Jed Christiansen
Special Projects & Business Development at Golden, Founder - Seed-DB. - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Rebecca Hammond
MA English I HDip Psychology - Following AI, behavioural and educational psychology - 6
Henry Ogolla
Passionate about reading and writing. - 7
Aime Anne Nisay
QA Engineer of web and mobile applications
